BioTesserae announced that its PD-1 single domain antibody, BTC-001, was well tolerated in a first-in-dog study, marking a key step toward new immunotherapy options for canine cancer.
Krka has launched Robexera® injectable, the first generic robenacoxib injection in the UK, offering veterinarians a cost-effective option for managing perioperative pain in dogs and cats.
Bimeda has announced the upcoming U.S. launch of Gastrobim™ (omeprazole), the first FDA-approved bioequivalent to GastroGard®, expanding access to equine gastric ulcer treatment.
The U.S. FDA has approved Gastrobim (omeprazole) oral paste, the first generic version of omeprazole paste for treating and preventing gastric ulcers in horses and foals.
Parnell has launched nixiFLOR, an FDA-approved injectable solution combining florfenicol and flunixin meglumine for the treatment of bovine respiratory disease and control of fever in beef and non-lactating dairy cattle.
Elanco Animal Health has secured a worldwide license to Syngulon’s antibiotic-free microbial selection technology to enhance fermentation efficiency in animal health product development.
The FDA has granted an emergency use authorization for F10 Antiseptic Wound Spray with Insecticide to prevent and treat New World screwworm in livestock, wildlife, and birds.
The FDA has approved an expanded label for BRAVECTO QUANTUM, adding 12-month protection against Asian longhorned and Gulf Coast ticks in dogs.
Authorization allows veterinarians to use NexGard® and NexGard® COMBO to treat New World screwworm infestations amid spread in Mexico.
Merck Animal Health has received FDA approval for NUMELVI™ (atinvicitinib tablets), the first and only second-generation JAK inhibitor indicated for control of pruritus associated with allergic dermatitis in dogs six months of age and older.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.